Key Highlights
•
Using the enhanced liver fibrosis (ELF) test and liver stiffness measurement in at-risk populations, researchers assessed the prevalence of steatotic liver disease in patients with type II diabetes mellitus. The study found that 45% of patients from a diabetes clinic had an ELF score below 9.5, and only 7.9% had liver stiffness readings ≥15 kPa, indicating that most diabetic patients had low risk for advanced fibrosis.
Source →
•
The study concluded that steatotic liver disease is common in individuals with type II diabetes, highlighting the importance of early screening strategies. These findings suggest that non-invasive testing can help identify patients who need further evaluation to prevent disease progression.
Source →
Stay curious. Stay informed —
Science Briefing
